Lung cancer has long stood as the most formidable cancer killer, burdened not only by late-stage diagnoses but also by decades of stigma and fatalism. Today, however, the landscape is shifting. Advances in screening, therapeutics, and survivorship have created a new reality; lung cancer is treatable, survivable, and increasingly understood as a chronic disease for many. The accompanying editorial from the American Cancer Society National Lung Cancer Roundtable [1] chronicles this progress and th…
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Common Determinants of Lung Cancer Screening Uptake in Three High-Risk and Underserved Communities
Though lung cancer screening (LCS) has significant mortality benefits and has been recommended by the US Preventive Services Task Force since 2013, uptake has been low, especially in most underserved populations. The objective of this study was to harmonize qualitative data from three parallel studies focused on communities with historically high rates of tobacco use and who face lung cancer disparities—people with human immunodeficiency virus; individuals that identify as lesbian, gay, bisexual…
-
Challenges and Opportunities for Rural Multidisciplinary Lung Cancer Care
Rural patient populations experience increased morbidity and mortality from lung cancer, the leading cause of cancer death in the United States. Lung cancer screening with low-dose chest CT reduces lung cancer deaths, yet rural patient populations experience barriers to screening, diagnosis, and treatment. The authors review challenges and opportunities across the continuum of multidisciplinary lung cancer care in rural communities. Specific focus is placed on innovative and scalable care delive…
-
A Vision Toward Risk-Stratified Postoperative Surveillance for Lung Cancer: Harnessing CT and AI
Survivors of lung cancer are an understudied but growing population with unmet needs. As of January 1, 2025, there were 680,450 lung cancer survivors in the United States, representing 3.6% of all cancer survivors [1]. This count is projected to increase considerably to 870,980 over the next decade, due to the growth and aging of the US population [2]. Combined with the rising incidence of pulmonary nodules [2], either detected by low-dose CT for lung cancer screening or incidentally from imagin…
-
Performance of CT-based Node-RADS for assessing cervical regional lymph Node metastasis in Papillary thyroid carcinoma
Thyroid cancer ranks as the seventh most common tumor globally in terms of incidence and fifth in women[1]. Papillary thyroid carcinoma (PTC) is the major subtype among thyroid malignancies, accounting for approximately 80 % of all thyroid cancers[2]. Cervical regional lymph node metastasis (LNM) is a risk factor associated with local recurrence and poor survival in patients with PTC, which can reach an incidence of 40 % − 90 %[3,4]. Furthermore, recurrence and persistent disease occurs in 30 % …
-
Clinical efficacy of the novel heat-balance technique in ultrasound-guided percutaneous microwave ablation for uterine fibroids: A retrospective study
To evaluate the clinical efficacy of the novel Heat-Balance Technique (HB type) in Ultrasound-Guided Percutaneous Microwave Ablation for Uterine Fibroids (PMWA).
-
Anaphylaxis in the Radiology Suite Often Refractory, Non-Resolving
(MedPage Today) — Anaphylactic reactions to iodinated contrast media (ICM) might be rare but cases that do occur often have a dangerous pattern of non-resolving or recurring symptoms despite treatment, a large analysis showed.
Out of more than…